Publications by authors named "A A Elsheikh"

Ectopic adrenocorticotropic hormone (ACTH)-dependent Cushing is a rare syndrome. We present a case that illustrates the diagnostic and therapeutic challenges of ectopic Cushing. A 35-year-old woman presented to the outpatient clinic for evaluation of progressive weight gain, muscle weakness, easy bruising, uncontrolled hypertension, and hyperglycemia.

View Article and Find Full Text PDF

Corneal cross-linking (CXL) is an effective method to prevent the progression of keratoconus. CXL combined with hypotonic riboflavin solution is a modified treatment for thin corneas, which are deemed to be below the safe thickness threshold. In this study, rabbit corneas were subjected to different hydration levels using different osmolarity of riboflavin dextran solutions before CXL.

View Article and Find Full Text PDF

Objective: To evaluate the diagnostic accuracy and reliability of the Ovarian-Adnexal Reporting and Data System (O-RADS) ultrasound v2019 in classifying adnexal masses (AMs) and compare the old and updated systems (v2022).

Patients And Methods: This prospective study enrolled 977 consecutive women with suspected AMs from three institutions between January 2022 and December 2023. Ultrasound examinations were performed by three experienced radiologists who categorized AMs according to O-RADS ultrasound v2019.

View Article and Find Full Text PDF

Nosemosis is one of the most devastating diseases of Apis mellifera (Honey bees) caused by the single-celled spore-forming fungi Nosema apis, N. ceranae and N. neumanii, causing a severe loss on the colony vitality and productivity.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to assess whether the effects of travoprost on corneal stiffness could revert after stopping the medication in rabbits.
  • In the experiment, rabbits were divided into three groups: treated with travoprost, those who had the drug withdrawn, and a blank control group, with various mechanical tests conducted on their corneas.
  • Results showed that while travoprost decreased corneal thickness and stiffness during treatment, the corneal properties of the drug withdrawal group appeared to recover after 12 weeks, resembling those of the control group.
View Article and Find Full Text PDF